Compare $APVO vs $ONCO | Chartloom

Compare

$APVO vs $ONCO

Aptevo Therapeutics Inc · Onconetix Inc

APVO

Aptevo Therapeutics Inc

ONCO

Onconetix Inc

Compare $APVO vs $ONCO

Comparing Aptevo Therapeutics Inc and Onconetix Inc

APVOAptevo Therapeutics Inc

ONCOOnconetix Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

ONCO

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

ONCO

Onconetix Inc

Market Cap

APVO$2M

ONCO$2M

Enterprise Value

APVO$-8M

ONCO$-3M

Price

APVO$1.79

ONCO$0.62

P/E Ratio

APVON/A

ONCON/A

P/S Ratio

APVO0.25x

ONCO3.79x

EV/Sales

APVO-0.51x

ONCO-5.18x

EV/EBITDA

APVO-0.91x

ONCO0.00x

P/B Ratio

APVO0.53x

ONCO0.24x

P/FCF Ratio

APVON/A

ONCON/A

EV/FCF

APVO0.30x

ONCO0.32x

PEG Ratio

APVON/A

ONCON/A

Forward P/E (NTM)

APVON/A

ONCON/A

Forward P/S (NTM)

APVON/A

ONCON/A

Revenue (TTM)

APVO$0

ONCO$646K

Revenue Growth (YoY)

APVON/A

ONCO-51.3%

Forward Rev Growth

APVO206.8%

ONCO0.0%

Gross Margin (TTM)

APVO51.4%

ONCO80.4%

Operating Margin (TTM)

APVO0.0%

ONCO0.0%

EBITDA Margin (TTM)

APVO0.0%

ONCO-1188.1%

Net Margin (TTM)

APVO0.0%

ONCO-1578.8%

FCF Margin (TTM)

APVON/A

ONCO-1596.2%

Net Income (TTM)

APVO$-28M

ONCO$-10M

FCF (TTM)

APVO$-25M

ONCO$-10M

EPS (TTM)

APVO-$23.47

ONCO-$4.55

ROE (TTM)

APVO-20149.0%

ONCO-9194.0%

ROA (TTM)

APVO-11921.0%

ONCO-5376.0%

ROIC (TTM)

APVO-20149.0%

ONCO-9080.0%

Cash

APVO$10M

ONCO$6M

Debt

APVO$0

ONCO$150K

Net Cash/Debt

APVO$10M

ONCO$6M

Current Ratio (TTM)

APVO2.08x

ONCO2.21x

Quick Ratio (TTM)

APVO1.98x

ONCO2.04x

Debt/Equity (TTM)

APVO0.00x

ONCO0.01x

Debt/Assets (TTM)

APVO0.0%

ONCO0.0%

Interest Coverage (TTM)

APVON/A

ONCON/A

Net Debt/EBITDA (TTM)

APVO0.00x

ONCO0.00x

Beta

APVO1.68

ONCO2.60

52W Performance

APVO-94.2%

ONCO-99.7%

YTD Performance

APVO-80.9%

ONCO-99.2%

% from 52W High

APVO-94.6%

ONCO-99.7%

% from 52W Low

APVO30.7%

ONCO6.9%

Asset Turnover (TTM)

APVO0.22x

ONCO0.03x

FCF Yield (TTM)

APVO-1132.6%

ONCO-420.9%

Earnings Yield (TTM)

APVO-1254.8%

ONCO-416.3%

Dividend Yield (TTM)

APVON/A

ONCON/A

Rule of 40

APVO0.0

ONCO-1,647.5

EV/GP/RG

APVON/A

ONCON/A

Ticker research

View APVO research View ONCO research

Metric	APVO Aptevo Therapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$-8M	$-3M
Price	$1.79	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	3.79x
EV/Sales	-0.51x	-5.18x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1188.1%
Net Margin (TTM)	0.0%	-1578.8%
FCF Margin (TTM)	N/A	-1596.2%
Net Income (TTM)	$-28M	$-10M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$23.47	-$4.55
ROE (TTM)	-20149.0%	-9194.0%
ROA (TTM)	-11921.0%	-5376.0%
ROIC (TTM)	-20149.0%	-9080.0%
Financial Health
Cash	$10M	$6M
Debt	$0	$150K
Net Cash/Debt	$10M	$6M
Current Ratio (TTM)	2.08x	2.21x
Quick Ratio (TTM)	1.98x	2.04x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.60
52W Performance	-94.2%	-99.7%
YTD Performance	-80.9%	-99.2%
% from 52W High	-94.6%	-99.7%
% from 52W Low	30.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.03x
FCF Yield (TTM)	-1132.6%	-420.9%
Earnings Yield (TTM)	-1254.8%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View ONCO research

Valuation

P/S Ratio

APVO

0.25x

ONCO

3.79x

EV/FCF

APVO

0.30x

ONCO

0.32x

Growth & revenue

Revenue Growth TTM

ONCO

-51.3%

Forward Revenue Growth

APVO

206.8%

ONCO

0.0%

Profitability & performance

Gross Margin

ONCO

80.4%

APVO

51.4%

ROE

ONCO

-9194.0%

APVO

-20149.0%

FCF Yield %

ONCO

-420.9%

APVO

-1132.6%

52-Week Performance

APVO

-94.2%

ONCO

-99.7%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

ONCO

Onconetix Inc

Market Cap

APVO$2M

ONCO$2M

Enterprise Value

APVO$-8M

ONCO$-3M

Price

APVO$1.79

ONCO$0.62

P/E Ratio

APVON/A

ONCON/A

P/S Ratio

APVO0.25x

ONCO3.79x

EV/Sales

APVO-0.51x

ONCO-5.18x

EV/EBITDA

APVO-0.91x

ONCO0.00x

P/B Ratio

APVO0.53x

ONCO0.24x

P/FCF Ratio

APVON/A

ONCON/A

EV/FCF

APVO0.30x

ONCO0.32x

PEG Ratio

APVON/A

ONCON/A

Forward P/E (NTM)

APVON/A

ONCON/A

Forward P/S (NTM)

APVON/A

ONCON/A

Revenue (TTM)

APVO$0

ONCO$646K

Revenue Growth (YoY)

APVON/A

ONCO-51.3%

Forward Rev Growth

APVO206.8%

ONCO0.0%

Gross Margin (TTM)

APVO51.4%

ONCO80.4%

Operating Margin (TTM)

APVO0.0%

ONCO0.0%

EBITDA Margin (TTM)

APVO0.0%

ONCO-1188.1%

Net Margin (TTM)

APVO0.0%

ONCO-1578.8%

FCF Margin (TTM)

APVON/A

ONCO-1596.2%

Net Income (TTM)

APVO$-28M

ONCO$-10M

FCF (TTM)

APVO$-25M

ONCO$-10M

EPS (TTM)

APVO-$23.47

ONCO-$4.55

ROE (TTM)

APVO-20149.0%

ONCO-9194.0%

ROA (TTM)

APVO-11921.0%

ONCO-5376.0%

ROIC (TTM)

APVO-20149.0%

ONCO-9080.0%

Cash

APVO$10M

ONCO$6M

Debt

APVO$0

ONCO$150K

Net Cash/Debt

APVO$10M

ONCO$6M

Current Ratio (TTM)

APVO2.08x

ONCO2.21x

Quick Ratio (TTM)

APVO1.98x

ONCO2.04x

Debt/Equity (TTM)

APVO0.00x

ONCO0.01x

Debt/Assets (TTM)

APVO0.0%

ONCO0.0%

Interest Coverage (TTM)

APVON/A

ONCON/A

Net Debt/EBITDA (TTM)

APVO0.00x

ONCO0.00x

Beta

APVO1.68

ONCO2.60

52W Performance

APVO-94.2%

ONCO-99.7%

YTD Performance

APVO-80.9%

ONCO-99.2%

% from 52W High

APVO-94.6%

ONCO-99.7%

% from 52W Low

APVO30.7%

ONCO6.9%

Asset Turnover (TTM)

APVO0.22x

ONCO0.03x

FCF Yield (TTM)

APVO-1132.6%

ONCO-420.9%

Earnings Yield (TTM)

APVO-1254.8%

ONCO-416.3%

Dividend Yield (TTM)

APVON/A

ONCON/A

Rule of 40

APVO0.0

ONCO-1,647.5

EV/GP/RG

APVON/A

ONCON/A

Ticker research

View APVO research View ONCO research

Metric	APVO Aptevo Therapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$-8M	$-3M
Price	$1.79	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	3.79x
EV/Sales	-0.51x	-5.18x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1188.1%
Net Margin (TTM)	0.0%	-1578.8%
FCF Margin (TTM)	N/A	-1596.2%
Net Income (TTM)	$-28M	$-10M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$23.47	-$4.55
ROE (TTM)	-20149.0%	-9194.0%
ROA (TTM)	-11921.0%	-5376.0%
ROIC (TTM)	-20149.0%	-9080.0%
Financial Health
Cash	$10M	$6M
Debt	$0	$150K
Net Cash/Debt	$10M	$6M
Current Ratio (TTM)	2.08x	2.21x
Quick Ratio (TTM)	1.98x	2.04x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.60
52W Performance	-94.2%	-99.7%
YTD Performance	-80.9%	-99.2%
% from 52W High	-94.6%	-99.7%
% from 52W Low	30.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.03x
FCF Yield (TTM)	-1132.6%	-420.9%
Earnings Yield (TTM)	-1254.8%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View ONCO research